for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Autolus Therapeutics PLC

AUTL.O

Latest Trade

15.44USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

3.00

 - 

17.19

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest News

BRIEF-Autolus Therapeutics Presents New Preclinical Data During The Virtual 2020 Aacr Annual Meeting

* AUTOLUS THERAPEUTICS PRESENTS NEW PRECLINICAL DATA DURING THE VIRTUAL 2020 AACR ANNUAL MEETING Source text for Eikon: Further company coverage:

BRIEF-Autolus Therapeutics Presents Additional Data On Auto3 In DLBCL During ASCO20 Virtual Scientific Program

* AUTOLUS THERAPEUTICS PRESENTS ADDITIONAL DATA ON AUTO3 IN DLBCL DURING THE ASCO20 VIRTUAL SCIENTIFIC PROGRAM

BRIEF-Autolus Therapeutics Q1 Loss Per Share $0.60

* AUTOLUS THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

BRIEF-Autolus Therapeutics Announces FDA Acceptance Of Ind Application For Auto1 For Adult Acute Lymphoblastic Leukemia

* AUTOLUS THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF IND APPLICATION FOR AUTO1 FOR ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

BRIEF-Molmed Signs Agreement With Autolus Therapeutics

* SIGNS AGREEMENT WITH AUTOLUS THERAPEUTICS FOR COOPERATION IN FIELD OF T-CELL THERAPIES Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Autolus Therapeutics PLC FY Loss Per Share $2.88

* AUTOLUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

BRIEF-Autolus Therapeutics Reports Qtrly Loss Per Share $2.88

* AUTOLUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up